Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million

Helen Louise Collins exercised and sold 40,000 common shares over March 9–10, 2026, generating approximately $1.20M in proceeds at a weighted average price of $30.07 per share. The sale followed an exercise and appears routine, unlikely to materially move the stock in isolation.

Analysis

Helen Louise Collins exercised and sold 40,000 common shares over March 9–10, 2026, generating approximately $1.20M in proceeds at a weighted average price of $30.07 per share. The sale followed an exercise and appears routine, unlikely to materially move the stock in isolation.